Skip navigation.

Neurocentric Health: Moving into the Mainstream

In our recent research, the Health Horizons program has been tracking the continuing maturity of what we call neurocentric health--the idea that the brain is becoming the focal point of a wide range of medical research and a whole host of new diagnostic and treatment tools. Taking a 10-year view, these big shifts in medical paradigms help guide long-term thinking and planning, including, for example, a shift in how we think about the concept of normality. 

 

Brain health is on my mind

Even as I write this, the Health Horizons team is in the middle of participating in the SharpBrains Virtual Summit, which you can follow on Twitter at IFTFHealth and/or using the hash tag #sharp2010. It turns out that today is a busy day for thinking about the brain.

In Defense of Generalists

The last decade has been witness to the rise of the geeks. What began as a glorification of tech entrepreneurs making it big from the rise of the IT industry, has now permeated every aspect of society. Single-minded obsession with obscure endeavors, hyper-specialization, and technical nerdery of all sorts are glorified across the board. But is such geekery really a good way to foster talent? The most pressing problems in science and technology, and more broadly in business and the economy, don't lend themselves readily to specialists' solutions.

Look Forward, and Carry a Big Stick

What is available to human experience is a result of the interaction between our brains, our biological bodies, and our environment (itself the result of social, historical, technological, and political processes). Our capacity to imagine 'what's possible' relies on neurological scaffolding that has been shaped by our current individual and collective knowledge and experience, often blinding us to a wide range of alternative futures.

The coming debate about brain enhancement

The New York Times recently had a pretty decent article about debates over brain enhancement in academia:

an era of doping may be looming in academia, and it has ignited a debate about policy and ethics that in some ways echoes the national controversy over performance enhancement accusations against elite athletes like Barry Bonds and Roger Clemens.

Syndicate content